[Preliminary results of a cooperative clinical study of the new antitumor antibiotic, carminomycin].
The clinical trials of karminomycin, a new Soviet antitumor antibiotic in treatment of different malignant tumors showed that the drug had a pronounced antitumor activity against the soft tissue sarcomas of various histogenesis, lympho- and reticulosarcoma, acute leukemia and some other neoplasms.
D000293:Adolescent; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002360:Carubicin / Q000627:therapeutic use* / Q000633:toxicity; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D012075:Remission, Spontaneous; D014586:USSR
D000903:Antibiotics, Antineoplastic; D002360:Carubicin
Predvaritel'nye rezul'taty kooperirovannogo klinicheskogo izucheniia novogo protivoopukholevogo antibiotika karminomitsina